Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
113.50    1.00 (0.89%)
Bid:
110.00
Ask:
117.00
Spread: 7.00 (6.364%)
Market Cap: £68.28m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Director/PDMR Shareholding

8 Jun 2009 17:28

RNS Number : 5627T
Intercede Group PLC
08 June 2009
 

Intercede Group plc ("Intercede" or the "Company")

Directors' Holdings in Company

And

Notification of Interest

Further to the conversion of loan notes to ordinary shares (the "Conversion") and the resultant increase in the Company's issued share capital announced on 1 June 2009, the Company has been advised of changes to the notifiable holdings of directors and significant shareholders as set out below:

The Company was notified on 5 June 2009 by the Trustees of The Azalia Trust, being persons connected with Jacques Tredoux, a director of Intercede, pursuant to DTR 3.1 and DTR 5.1, that on 1 June 2009 The Azalia Trust indirectly acquired through controlled undertakings an aggregate of 5,740,485 ordinary shares of 1p each in the Company as a result of electing to convert the Trust's indirect interests in convertible loan notes at the conversion prices of 20p and 15p per share. Following the conversion, the Trust now has an aggregate indirect holding of 11,063,128 ordinary shares, representing 22.96% of the issued ordinary share capital of the Company.

The controlled undertakings of The Azalia Trust with disclosable holdings are:

Name of undertaking

Number of shares acquired as a result of Conversion

Existing shareholding prior to Conversion

Percentage holding following Conversion

Friskney Enterprises Limited

1,800,545

0

3.74%

Ferrybridge Enterprises Limited

1,854,907

0

3.85%

React Invest Limited*

2,085,033

1,344,683

7.12%

* React Invest Limited hold a further 402,448 shares which are not for the beneficial interest of Azalia Trust giving a total shareholding of 3,832,164 shares (7.95%).

The Company was notified on 5 June 2009 by the Trustees of The Woodcock Trust, being persons connected with Jacques Tredoux, pursuant to DTR 5.1.2 (2), that as a result of the increase in the issued share capital of the Company, The Woodcock Trust is now indirectly holding 3.04% of the Company's issued share capital, having previously held 4.31% of the same. The 1,463,216 shares in which the Trust is interested are registered in the name of Pershing Keen Nominees Limited, which is a nominee of Angus Investment Holdings Limited ("Angus"). Angus is controlled by The Woodcock Trust, of which Jacques Tredoux and his wife and children are members of the class of discretionary beneficiaries.

The holdings of the directors of the Company following the Conversion are as set out in the table below:

Director

No. of shares held

% of issued share capital

R A Parris

6,472,232

13.43%

A M Walker

1,248,077

2.59%

R Hoggarth

168,721

0.35%

J S Sikorski

106,686

0.22%

The Azalia Trust and The Woodcock Trust have an aggregate indirect holding of 12,526,344 ordinary shares in the Company (26.00%). Although Jacques Tredoux does not have any direct holdings in the ordinary shares of the Company, he and his wife and children are members of the class of discretionary beneficiaries under the Trusts.

The Company wishes to clarify other significant shareholdings as at 5 June 2009 resulting from the Conversion and increase in its issued share capital to 48,178,005 ordinary shares.

Shareholder

No. of shares held

% of issued share capital

Anjar International Limited

3,241,631

6.73%

Plastic Technologies Ltd

3,147,436

6.53%

Barclayshare Nominees Limited

1,655,661

3.42%

Cogefin (Bermuda) Limited

1,582,541

3.28%

Hargreave Hale Nominees Limited

1,568,788

3.26%

For further information please visit www.intercede.com or contact:

Andrew Walker Intercede Group plc 01455 558 111

Charles Cunningham FinnCap 020 7600 1658

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQVLFBKQBLBBD
Date   Source Headline
7th Nov 20237:00 amRNSContract and Renewals Orders
25th Oct 20234:44 pmRNSDirector/PDMR Shareholding
24th Oct 20237:00 amRNSNotice of Interim Results & Investor Presentation
20th Oct 20237:03 amRNSAppointment of Non-Executive Director
11th Oct 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20237:00 amRNSTrading Update
21st Sep 20231:31 pmRNSResult of AGM
4th Sep 20237:00 amRNSContract and Renewals Orders
30th Aug 20237:10 amRNSNotice of AGM and Publication of Annual Report
20th Jun 20237:01 amRNSBoard Changes
20th Jun 20237:00 amRNSFinal Results
12th Jun 20237:00 amRNSNotice of Results & Investor Presentation
27th Apr 20237:00 amRNSShare Incentive Plan
17th Apr 20237:00 amRNSTrading Update
3rd Apr 20237:00 amRNSContract wins/renewals
3rd Feb 202310:46 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSChange of Auditors
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
23rd Jan 20232:00 pmRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSTrading Update
11th Jan 20232:30 pmRNSDirector/PDMR Shareholding
2nd Dec 20228:45 amRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSHalf-year Report
11th Nov 20227:00 amRNSNotice of Interim Results & Investor Presentation
13th Oct 202210:30 amRNSDirector/PDMR Shareholding
11th Oct 20221:00 pmRNSDirector/PDMR Shareholding
10th Oct 20228:00 amRNSLong Term Incentive Plan
10th Oct 20227:01 amRNSAcquisition of Authlogics Ltd
10th Oct 20227:00 amRNSTrading Update
28th Sep 202212:22 pmRNSResult of AGM
15th Sep 20227:00 amRNSDirector/PDMR Shareholding and Issue of Equity
10th Aug 20227:00 amRNSNotice of AGM
30th Jun 20227:00 amRNSBoard Changes
8th Jun 20227:00 amRNSFinal Results
25th May 202210:15 amRNSInvestor Presentation
12th Apr 20227:00 amRNSAppointment of CFO
6th Apr 20227:00 amRNSDirector/PDMR Shareholding
5th Apr 20227:00 amRNSTrading Update & Contract Win
30th Mar 202210:01 amRNSReceipt of $3.4m Order
2nd Feb 20227:00 amRNSContract Win
8th Dec 20213:55 pmRNSDirector/PDMR Shareholding and Issue of Equity
23rd Nov 20217:00 amRNSHalf-year Report
19th Nov 20217:00 amRNSHolding(s) in Company-Amendment
17th Nov 20217:00 amRNSInvestor Presentation
16th Nov 20217:00 amRNSHolding(s) in Company
15th Nov 20213:45 pmRNSTotal Voting Rights
11th Nov 20214:12 pmRNSHolding(s) in Company
11th Oct 20217:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.